Antonio Anzueto, MD
Enriched profileProfessor of Medicine; Section Chief of Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System · University of Texas Health Science Center at San Antonio
Antonio Anzueto is Professor of Medicine; Section Chief of Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System at University of Texas Health Science Center at San Antonio. OpenAlex indexes 591 publications with 67,933 citations (h-index 85); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Antonio Anzueto, MD, is Professor of Medicine at University of Texas Health Science Center at San Antonio (UT Health San Antonio), Long School of Medicine, Division of Pulmonary Diseases & Critical Care Medicine. The public record shows 591 publications with 67,933 citations (h-index 85), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Pneumonia and Respiratory Infections, Respiratory Support and Mechanisms. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 25 companies, 1 NIH-funded awards (2001–2001).
- Most recent indexed publication: 2026 · Allergy
- Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 279.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Co-author
ATS/IDSA Official Clinical Practice Guideline: Diagnosis and Treatment of Adults with Community-acquired Pneumonia
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Third International Study on Mechanical Ventilation
Sponsor: Hospital Universitario Getafe
- Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Industry payments
Updated 14 Oct 2026
25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202541 payments$124,287openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202594 payments$106,117openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year202559 payments$95,156openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
86.3%beta2-Adrenergic Agonist50.5%Albuterol71%Albuterol Sulfate Hfa22%Ventolin Hfa7%Part D + Part B<11 patientsCorticosteroid28.9%Breo Ellipta35%Breztri Aerosphere31%Trelegy Ellipta27%Dulera7%Part D<11 patients+ 2 more classes in this area
Anti-infectives
7.4%Macrolide Antimicrobial4.7%Azithromycin100%Part D≥17 patientsPenicillins with extended spectrum2.7%Amoxicillin-Clavulanate Potass100%Part D≥14 patientsMetabolism & gastrointestinal
4.3%Corticosteroid4.3%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2001–2001 per NIH RePORTER. The latest:
- TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
University of Texas Hlth Sci Ctr San Ant
FY2001$204,390N01HR016153
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Ensifentrine in COPD patients taking long-acting bronchodilators: A pooled post-hoc analysis of the ENHANCE-1/2 studies.
Chronic respiratory disease
Clinical Trial2025 - Long-acting muscarinic antagonist and long-acting β(2)-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review.
Therapeutic advances in respiratory disease
Review2024 - Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
Annals of the American Thoracic Society
Article2022 - Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.
American journal of respiratory and critical care medicine
Guideline2019
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/antonio-anzueto-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Antonio-Anzueto-38375480
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/hcplive_dr-antonio-anzueto-invites-you-to-a-copd-activity-7194871390234181632-0ziV
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/vumedi-pulmonology_2026-gold-report-copd-disease-activity-activity-7436738816885002240-QGS5
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
pulmcast.com/podcast/gold-copd-guidelines-anzueto
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmcast.com ↗ - Spotify
open.spotify.com/episode/13FrmJqR4EgrZnmJpCCmjd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗ - X / Twitter
x.com/PeerView/status/1988994851040321991
- X / Twitter
x.com/Pulm_Vumedi/status/2031018922573795520
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- Board Certified
American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Committee member
ATS/ERS COPD Guidelines (2004, 2010) and COPD Exacerbation Guidelines (2018); ATS/ERS/ESICM ARDS working group (2012); ATS/IDSA Community-Acquired Pneumonia Guidelines
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →adventprogram.com ↗ - Section Chief of Pulmonary/Critical Care Medicine
South Texas Veterans Health Care System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗ - Executive and Scientific Committee member
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →adventprogram.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →adventprogram.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →adventprogram.com ↗
- Teacher of the Year
University of Texas Health San Antonio (year not specified)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.com ↗
Secondary affiliations
appointments beyond the home institution- South Texas Veterans Health Care System (VA) - Section Chief
Pulmonary/Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗ - University Health / University Hospital
San Antonio, TX - affiliated provider
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →universityhealth.com ↗
Media & interviews
press, podcasts and appearances- The Curbsiders podcast
episode #356: "Chronic Obstructive Pulmonary Disease (COPD) Update with Dr. Antonio Anzueto"
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thecurbsiders.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmcast.com ↗
- AJMC video interview series on COPD developments
triple therapy, and COPD-cardiovascular disease ties
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emjreviews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital